Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHR1 | P34998 | 3/20 | 0.42 |
| ▸ | PPARD | Q03181 | 13/20 | 0.40 |
| ▸ | PPARA | Q07869 | 8/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.38 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 4/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4097716 | 0.91 | PPARD (0.49) | CRHR1PPARDPPARAPPARG | |
| SCHEMBL4095815 | 0.88 | CRHR1 (0.40) | CRHR1PPARDPPARATRPM2SLC34A1 | |
| SCHEMBL4091081 | 0.87 | PPARD (0.43) | PPARDPPARAPPARG | |
| SCHEMBL4095633 | 0.85 | PPARD (0.45) | CRHR1PPARDPPARAPPARG | |
| SCHEMBL4105039 | 0.84 | CRHR1 (0.43) | CRHR1 | |
| SCHEMBL4090780 | 0.79 | PPARD (0.47) | PPARDPPARAPPARG | |
| SCHEMBL4095560 | 0.79 | PPARD (0.51) | PPARDPPARAPPARG | |
| SCHEMBL4105650 | 0.76 | PPARD (0.51) | PPARDPPARAPPARG | |
| SCHEMBL14573029 | 0.74 | PPARD (0.63) | PPARDPPARAPPARG | |
| SCHEMBL4090763 | 0.74 | PPARD (0.42) | PPARDPPARAPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090240058-A1 | Activator for Peroxisome Proliferator-Activating Receptor Delta | NIPPON CHEMIPHAR CO., LTD. (JP) | 2009-09-24 | — | — | US | disclosed |
| EP-1854784-A1 | ACTIVATOR FOR PEROXISOME PROLIFERATOR ACTIVATING RECEPTOR | Nippon Chemiphar Co., Ltd. (JP) | 2007-11-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090240058-A1 | Activator for Peroxisome Proliferator-Activating Receptor Delta | PPARG, PPARA, PPARD | CRHR1 1324/4885PPARD 3/4885PPARA 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.